Esperion Therapeutics, Inc. (ESPR) Insider Ownership

Historic Insider Ownership Trends

Data spanning the past 90 days through February 07, 2026 reveals that Esperion Therapeutics's three principal insider shareholders consist of TenPercentOwner Target N V Biotech (4.48Mn shares), President And Ceo Sheldon L. Koenig (1.47Mn shares), Chief Financial Officer Benjamin Halladay (467.52K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Target N V Biotech 4,477,964 26 May, 2021
Sheldon L. Koenig President And Ceo 1,470,587 18 Dec, 2025
Benjamin Halladay Chief Financial Officer 467,525 18 Dec, 2025
John B. Jr. Harlow Chief Commercial Officer 424,536 08 Dec, 2025
Benjamin Looker General Counsel 384,216 21 Jan, 2026
Eric Warren Chief Commercial Officer 370,218 21 Apr, 2025
Joanne M. Foody Chief Medical Officer 272,862 19 Jul, 2024
J Martin Carroll 97,650 02 Jun, 2025
Jay Shepard 84,599 02 Jun, 2025
Richard Bartram Chief Financial Officer 82,751 16 Mar, 2022
Stephen Rocamboli 69,261 02 Jun, 2025
Seth H. Z. Fischer 61,150 02 Jun, 2025
Alan Fuhrman 53,404 24 May, 2024
Antonio M Jr Md D Phil Gotto 51,599 24 May, 2024
Nicole Vitullo 36,918 16 Jun, 2023
Tracy M Woody 33,566 16 Jun, 2023
Mark E Mcgovern 28,449 28 May, 2021
Jeffrey Berkowitz 23,449 28 May, 2021
Daniel Janney 23,449 28 May, 2021
Robert E. Hoffman 5,280 02 Jun, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
20 Jan, 2026 Benjamin Looker Common Stock D 1,689 $2.88 384,216 D S
17 Dec, 2025 Sheldon L. Koenig Common Stock D 48,244 $3.67 1,470,587 D S
17 Dec, 2025 Benjamin Looker Common Stock D 6,517 $3.67 385,905 D S
17 Dec, 2025 Benjamin Halladay - - 467,525 D
17 Dec, 2025 Benjamin Halladay Common Stock D 7,337 $3.67 467,525 D S
04 Dec, 2025 John B. Jr. Harlow - - 424,536 D
04 Dec, 2025 John B. Jr. Harlow Common Stock A 424,536 $0.00 424,536 D A
17 Oct, 2025 Benjamin Looker Common Stock D 1,248 $2.62 392,422 D S
17 Sep, 2025 Sheldon L. Koenig Common Stock D 28,427 $2.79 1,518,831 D S
17 Sep, 2025 Benjamin Looker Common Stock D 6,267 $2.80 393,670 D S
17 Sep, 2025 Benjamin Halladay Common Stock D 7,046 $2.81 474,862 D S
17 Jul, 2025 Benjamin Looker Common Stock D 1,304 $1.13 399,937 D S
17 Jul, 2025 Benjamin Halladay Common Stock D 11 $1.12 474,462 D S
17 Jun, 2025 Sheldon L. Koenig Common Stock D 30,474 $1.11 1,541,488 D S
17 Jun, 2025 Benjamin Looker Common Stock D 6,422 $1.15 401,241 D S
17 Jun, 2025 Benjamin Halladay Common Stock D 7,229 $1.15 474,473 D S
29 May, 2025 Robert E. Hoffman Common Stock A 5,280 $0.00 5,280 D A
29 May, 2025 Stephen Rocamboli Common Stock A 33,000 $0.00 69,261 D A
29 May, 2025 Stephen Rocamboli - - 69,261 D
29 May, 2025 J Martin Carroll Common Stock A 33,000 $0.00 97,650 D A